Literature DB >> 4029620

Multiple-cloning-site plasmids for the rapid construction of recombinant poxviruses.

D B Boyle, B E Coupar, G W Both.   

Abstract

Plasmid vectors containing multiple cloning sites suitable for the rapid insertion of protein-coding sequences into poxviruses have been constructed. They are based on pUC plasmids and carry the thymidine kinase (TK) gene of vaccinia virus interrupted by a vaccinia virus promoter. Six unique restriction enzyme sites (BamHI, SalI/HincII, PstI, HindIII, EcoRI), located within 40 bp of vaccinia virus promoters transposed from the HindIII-F or HindIII-C fragment of the vaccinia virus genome, allow rapid insertion of foreign-protein-coding sequences into these plasmids. Such plasmids can be used to construct recombinant poxviruses expressing foreign proteins using marker-rescue recombination techniques and selection for TK negative viruses. Vaccinia viruses expressing the haemagglutinin (HA) gene of swine influenza virus, A/NJ/11/76 (H1N1), have been constructed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4029620     DOI: 10.1016/0378-1119(85)90169-6

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  21 in total

1.  Processing of dengue virus type 2 structural proteins containing deletions in hydrophobic domains.

Authors:  A Gruenberg; P J Wright
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

2.  Expression of the NS1 gene of dengue virus type 2 using vaccinia virus. Dimerisation of the NS1 glycoprotein.

Authors:  C R Parrish; W S Woo; P J Wright
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

3.  Minimal epitopes expressed in a recombinant polyepitope protein are processed and presented to CD8+ cytotoxic T cells: implications for vaccine design.

Authors:  S A Thomson; R Khanna; J Gardner; S R Burrows; B Coupar; D J Moss; A Suhrbier
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

4.  The immunogenicity of VP7, a rotavirus antigen resident in the endoplasmic reticulum, is enhanced by cell surface expression.

Authors:  M E Andrew; D B Boyle; P L Whitfeld; L J Lockett; I D Anthony; A R Bellamy; G W Both
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

5.  Topography and immunogenicity of bluetongue virus VP7 epitopes.

Authors:  L F Wang; A D Hyatt; P L Whiteley; M Andrew; J K Li; B T Eaton
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

6.  Flavivirus premembrane protein cleavage and spike heterodimer secretion require the function of the viral proteinase NS3.

Authors:  M Lobigs
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

7.  A comparative analysis of HIV-specific mucosal/systemic T cell immunity and avidity following rDNA/rFPV and poxvirus-poxvirus prime boost immunisations.

Authors:  Charani Ranasinghe; Fiona Eyers; John Stambas; David B Boyle; Ian A Ramshaw; Alistair J Ramsay
Journal:  Vaccine       Date:  2011-02-23       Impact factor: 3.641

8.  Vaccinia virus recombinants expressing the SA11 rotavirus VP7 glycoprotein gene induce serotype-specific neutralizing antibodies.

Authors:  M E Andrew; D B Boyle; B E Coupar; P L Whitfeld; G W Both; A R Bellamy
Journal:  J Virol       Date:  1987-04       Impact factor: 5.103

9.  Protection of sheep against bovine leukemia virus (BLV) infection by vaccination with recombinant vaccinia viruses expressing BLV envelope glycoproteins: correlation of protection with CD4 T-cell response to gp51 peptide 51-70.

Authors:  M H Gatei; H M Naif; S Kumar; D B Boyle; R C Daniel; M F Good; M F Lavin
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

10.  Quantitative assessment of poxvirus promoters in fowlpox and vaccinia virus recombinants.

Authors:  D B Boyle
Journal:  Virus Genes       Date:  1992-08       Impact factor: 2.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.